-
Entity
-
Individual
-
Location
-
C/O Aspreva Pharmaceuticals Corporation, 1203 4464 Markham Street, Victoria, British Columbia, Canada
-
Summary
-
The estimated net worth of Michael R. Hayden is at least $17.7 M dollars as of July 3, 2024. Michael R. Hayden is the Director of AbCellera Biologics Inc. and owns shares of AbCellera Biologics Inc. (ABCL) stock worth about $10.9 M. Michael R. Hayden is the Director of Xenon Pharmaceuticals Inc. and owns shares of Xenon Pharmaceuticals Inc. (XENE) stock worth about $3.18 M. Michael R. Hayden is the Director of IONIS PHARMACEUTICALS INC and owns shares of IONIS PHARMACEUTICALS INC (IONS) stock worth about $1.98 M. Michael R. Hayden is the Director of 89bio, Inc. and owns shares of 89bio, Inc. (ETNB) stock worth about $1.64 M.